These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5307078)

  • 41. Comparative deterministic effects of inhaled, insoluble alpha- and beta-particle-emitting radionuclides in dogs.
    Muggenburg BA; Hahn FF; Ménache MG; Guilmette RA; Boecker BB
    Radiat Res; 1999 Dec; 152(6 Suppl):S23-6. PubMed ID: 10564930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA.
    Stradling GN; Stather JW; Sumner SA; Strong JC; Lennox AM; Ham SE
    Health Phys; 1984 Apr; 46(4):919-24. PubMed ID: 6706599
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparative toxicity of inhaled 238PuO2 and 239PuO2 in rats. BNWL-714.
    Stuart BO; Bair WJ
    BNWL Rep; 1968 May; ():4.11-4+. PubMed ID: 5307080
    [No Abstract]   [Full Text] [Related]  

  • 44. Lung fibrosis and lung cancer incidence in beagle dogs that inhaled 238PuO2 or 239PuO2.
    Wilson D
    Health Phys; 2009 Feb; 96(2):175-85. PubMed ID: 19131739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical effects of inhaled 239PuO2 on lung lipids.
    Tombropoulos EG; Hadley JG; Thomas JM; Craig DK
    Health Phys; 1977 Feb; 32(2):111-3. PubMed ID: 849887
    [No Abstract]   [Full Text] [Related]  

  • 46. Distribution of inhaled 239PuO2 particles within pulmonary macrophages. BNWL-1050.
    Sanders CL
    BNWL Rep; 1970 Jan; ():3.35+. PubMed ID: 5311277
    [No Abstract]   [Full Text] [Related]  

  • 47. Biliary excretion of plutonium after pulmonary deposition in rats. BNWL-714.
    Matsusaka N; Bair WJ
    BNWL Rep; 1968 May; ():3.20-3+. PubMed ID: 5307069
    [No Abstract]   [Full Text] [Related]  

  • 48. Calculation of organ and tissue burdens and doses resulting from an acute exposure to a radioactive aerosol using the ICRP Task Group report on the human respiratory tract. IDO-12067.
    Voillequé PG
    IDO Rep; 1968 Jun; ():1-44. PubMed ID: 5713429
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of time on the determination of the clearance rates of insoluble plutonium 239 oxide.
    Métivier H; Masse R; Nolibé D; Lafuma J
    Health Phys; 1977 May; 32(5):447-50. PubMed ID: 407176
    [No Abstract]   [Full Text] [Related]  

  • 50. Cellular interactions with plutonium particles. BNWL-1221.
    BNWL Rep; 1970 Feb; ():5.1+. PubMed ID: 5311145
    [No Abstract]   [Full Text] [Related]  

  • 51. Lung, liver and bone cancer mortality after plutonium exposure in beagle dogs and nuclear workers.
    Wilson DA; Mohr LC; Frey GD; Lackland D; Hoel DG
    Health Phys; 2010 Jan; 98(1):42-52. PubMed ID: 19959950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biokinetics of inhaled 239PuO2 in the beagle dog: effect of aerosol particle size.
    Guilmette RA; Diel JH; Muggenburg BA; Mewhinney JA; Boecker BB; McClellan RO
    Int J Radiat Biol Relat Stud Phys Chem Med; 1984 Jun; 45(6):563-81. PubMed ID: 6610656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological effects of inhaled 238PuO2 in beagles.
    Park JF; Buschbom RL; Dagle GE; James AC; Watson CR; Weller RE
    Radiat Res; 1997 Oct; 148(4):365-81. PubMed ID: 9339953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retention of 239Pu in the mouse lung and estimation of consequent dose following inhalation of sized 239PuO2.
    Morgan A; Black A; Moores SR; Lambert BE
    Radiat Res; 1984 Aug; 99(2):272-84. PubMed ID: 6463206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro dissolution study of plutonium in aerosol particles from the Mayak PA: a tool for individualised dose estimates.
    Aladova EE; Romanov SA; Guilmette RA; Khokhryakov VF; Suslova KG
    Radiat Prot Dosimetry; 2007; 127(1-4):60-3. PubMed ID: 17704503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissolution characteristics of plutonium aerosols in lung serum simulant.
    Vashi VD; Suryanarayanan CS; Kotrapp P
    Health Phys; 1980 Jul; 39(1):105-8. PubMed ID: 7419399
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of predicted with observed biokinetics of inhaled plutonium nitrate and gadolinium oxide in humans.
    Hodgson A; Shutt AL; Etherington G; Hodgson SA; Rance E; Stradling GN; Youngman MJ; Ziesenis A; Kreyling WG
    Radiat Prot Dosimetry; 2003; 105(1-4):91-4. PubMed ID: 14526934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Role of phagocytosis and the effect of different DTPA salts on the mechanism of lung self-purification of 239Pu].
    Levdik TI; Osobets SV
    Med Radiol (Mosk); 1980 Oct; 25(10):44-8. PubMed ID: 7421452
    [No Abstract]   [Full Text] [Related]  

  • 59. Removal of inhaled 239PuO2 in rats. BNWL-714.
    Dilley JV; McDonald KE
    BNWL Rep; 1968 May; ():6.9-6+. PubMed ID: 5307102
    [No Abstract]   [Full Text] [Related]  

  • 60. Removal of inhaled 239PuO2 from beagle dogs by pulmonary lavage.
    McDonald KE; Park JF; Dagle GE; Sanders CL; Olson RJ
    Health Phys; 1975 Nov; 29(5):804-5. PubMed ID: 1193904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.